Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 0.18 is 74% below its 4-year average of 0.68, near the low end of its 4-year range (0.00–20.91).
As of the fiscal period ended Tuesday, June 30, 2026. 70.89% below its 12-month average of 0.60.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.18.
QUICK RATIO (ACID-TEST)
0.18
QUICK RATIO (ACID-TEST) AVG TTM
0.60
QUICK RATIO (ACID-TEST) AVG 3Y
0.68
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-70.89%
CURRENT VS 3Y AVG
-74.13%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
-94.75%
vs the sector median at left
Mangoceuticals, Inc.
Market Cap
$7.30M
Quick Ratio (Acid-Test)
0.18
TTM Avg
0.60
3Y Avg
0.68
5Y Avg
N/A
Market Cap
$7.29M
Quick Ratio (Acid-Test)
0.95
TTM Avg
9.81
3Y Avg
5.30
5Y Avg
4.51
Market Cap
$7.25M
Quick Ratio (Acid-Test)
0.31
TTM Avg
1.26
3Y Avg
1.91
5Y Avg
5.52
Market Cap
$7.36M
Quick Ratio (Acid-Test)
1.37
TTM Avg
3.92
3Y Avg
4.12
5Y Avg
3.73
Market Cap
$7.18M
Quick Ratio (Acid-Test)
2.63
TTM Avg
4.46
3Y Avg
3.65
5Y Avg
4.69
Market Cap
$7.07M
Quick Ratio (Acid-Test)
1.52
TTM Avg
3.93
3Y Avg
10.24
5Y Avg
10.80
Market Cap
$7.56M
Quick Ratio (Acid-Test)
14.52
TTM Avg
3.29
3Y Avg
11.30
5Y Avg
10.20
Market Cap
$7.65M
Quick Ratio (Acid-Test)
7.10
TTM Avg
3.48
3Y Avg
3.44
5Y Avg
4.75
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mangoceuticals, Inc. (MGRX) | $7.30M | 0.18 | 0.60 | 0.68 | N/A |
| Skye Bioscience, Inc. (SKYE)vs › | $7.29M | 0.95 | 9.81 | 5.30 | 4.51 |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $7.25M | 0.31 | 1.26 | 1.91 | 5.52 |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.36M | 1.37 | 3.92 | 4.12 | 3.73 |
| Longeveron Inc. (LGVN)vs › | $7.18M | 2.63 | 4.46 | 3.65 | 4.69 |
| Co-Diagnostics, Inc. (CODX)vs › | $7.07M | 1.52 | 3.93 | 10.24 | 10.80 |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.56M | 14.52 | 3.29 | 11.30 | 10.20 |
| KALA BIO, Inc. (KALA)vs › | $6.99M | 6.88 | 3.46 | 4.15 | 4.53 |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.65M | 7.10 | 3.48 | 3.44 | 4.75 |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $6.89M | 45.95 | 58.73 | 40.89 | 40.89 |
Quick Ratio
0.18
Excludes inventory
Current Ratio
0.18
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 0.18 |
| 2026-03-31 | 0.29 |
| 2025-12-31 | 1.74 |
| 2025-09-30 | 0.74 |
| 2025-06-30 | 0.07 |
| 2025-03-31 | 0.12 |
| 2024-12-31 | 0.05 |
| 2024-09-30 | 0.07 |
| 2024-06-30 | 0.37 |
| 2024-03-31 | 0.06 |
| 2023-12-31 | 3.79 |
| 2023-09-30 | 8.30 |
| 2023-06-30 | 15.27 |
| 2023-03-31 | 20.91 |
| 2022-12-31 | 2.67 |
| 2022-09-30 | 9.95 |
| 2022-06-30 | 0.01 |
| 2022-03-31 | 0.00 |
| 2021-12-31 | 0.00 |
